- Belimumab and Rituximab for the Treatment of Primary Membranous Nephropathy: Initial REBOOT Results
10:00 AM - 12:00 PM
Belimumab and Rituximab for the Treatment of Primary Membranous Nephropathy: Initial REBOOT Results
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 1b, Single-Arm, Open-Label Study of Budoprutug, an Anti-CD19 Monoclonal Antibody with Enhanced Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), in Primary Membranous Nephropathy
10:00 AM - 12:00 PM
A Phase 1b, Single-Arm, Open-Label Study of Budoprutug, an Anti-CD19 Monoclonal Antibody with Enhanced Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC), in Primary Membranous Nephropathy
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Randomized Controlled Trial Comparing Rituximab to Mycophenolate Mofetil in Children and Young Adults with Steroid-Dependent Idiopathic Nephrotic Syndrome
10:00 AM - 12:00 PM
Randomized Controlled Trial Comparing Rituximab to Mycophenolate Mofetil in Children and Young Adults with Steroid-Dependent Idiopathic Nephrotic Syndrome
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Updated Results with Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Primary Membranous Nephropathy (RUBY-3 Study)
10:00 AM - 12:00 PM
Updated Results with Povetacicept, an Enhanced Dual BAFF/APRIL Antagonist, in Primary Membranous Nephropathy (RUBY-3 Study)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- CD19 Repopulation and Anti-phospholipase A2 Receptor (PLA2R) following Rituximab in Membranous Nephropathy
10:00 AM - 12:00 PM
CD19 Repopulation and Anti-phospholipase A2 Receptor (PLA2R) following Rituximab in Membranous Nephropathy
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Comparative Analysis of Efficacy of Rituximab in Patients with Primary Membranous Nephropathy
10:00 AM - 12:00 PM
A Comparative Analysis of Efficacy of Rituximab in Patients with Primary Membranous Nephropathy
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Long-Term Outcome of Adult Patients with Membranous Nephropathy Treated with Rituximab
10:00 AM - 12:00 PM
Long-Term Outcome of Adult Patients with Membranous Nephropathy Treated with Rituximab
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Obinutuzumab Is Effective and Safe for Membranous Nephropathy with Very High Risk: A Retrospective Study from China
10:00 AM - 12:00 PM
Obinutuzumab Is Effective and Safe for Membranous Nephropathy with Very High Risk: A Retrospective Study from China
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Outcomes in Membranous Nephropathy Treated with Intravenous Cyclophosphamide and Oral Prednisolone (Modification of the Modified Ponticelli Regimen): A Single-Centre Experience
10:00 AM - 12:00 PM
Outcomes in Membranous Nephropathy Treated with Intravenous Cyclophosphamide and Oral Prednisolone (Modification of the Modified Ponticelli Regimen): A Single-Centre Experience
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Assessing the Rates of Complications in Patients with Membranous Nephropathy Treated with Cyclical Intravenous Cyclophosphamide and Oral Prednisolone: A Single-Centre Experience
10:00 AM - 12:00 PM
Assessing the Rates of Complications in Patients with Membranous Nephropathy Treated with Cyclical Intravenous Cyclophosphamide and Oral Prednisolone: A Single-Centre Experience
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Effect of Phospholipase A2 Receptor (PLA2R) Antibody and Inflammatory Factors on Cardiovascular and Thromboembolic Events in Patients with Primary Membranous Nephropathy
10:00 AM - 12:00 PM
Effect of Phospholipase A2 Receptor (PLA2R) Antibody and Inflammatory Factors on Cardiovascular and Thromboembolic Events in Patients with Primary Membranous Nephropathy
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Comparability of Two Anti-phospholipase A2 Receptor (PLA2R) Enzyme-Linked Immunosorbent Assays (ELISAs) in Patients with Primary Membranous Nephropathy
10:00 AM - 12:00 PM
Comparability of Two Anti-phospholipase A2 Receptor (PLA2R) Enzyme-Linked Immunosorbent Assays (ELISAs) in Patients with Primary Membranous Nephropathy
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Noninvasive Diagnostic Strategies for Membranous Nephropathy in the NEPTUNE Study
10:00 AM - 12:00 PM
Noninvasive Diagnostic Strategies for Membranous Nephropathy in the NEPTUNE Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Assessment of Endothelial Dysfunction in Patient with Phospholipase A2 Receptor (PLA2R)-Positive Primary Membranous Nephropathy in Remission
10:00 AM - 12:00 PM
Assessment of Endothelial Dysfunction in Patient with Phospholipase A2 Receptor (PLA2R)-Positive Primary Membranous Nephropathy in Remission
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Assessing the Utility and Accuracy of Phospholipase A2 Receptor (PLA2R) Antibody in Membranous Nephropathy: A Systematic Review and Meta-Analysis
10:00 AM - 12:00 PM
Assessing the Utility and Accuracy of Phospholipase A2 Receptor (PLA2R) Antibody in Membranous Nephropathy: A Systematic Review and Meta-Analysis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial
10:00 AM - 12:00 PM
Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Characterization of the Immune-Dominant Region on the CysR Domain of Phospholipase A2 Receptor 1 (PLA2R1) Targeted by Autoreactive Memory B Cells
10:00 AM - 12:00 PM
Characterization of the Immune-Dominant Region on the CysR Domain of Phospholipase A2 Receptor 1 (PLA2R1) Targeted by Autoreactive Memory B Cells
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Laser Microdissection and Mass Spectrometry: A Reliable Clinical Test for Detection of Membranous Nephropathy (MN) Antigens
10:00 AM - 12:00 PM
Laser Microdissection and Mass Spectrometry: A Reliable Clinical Test for Detection of Membranous Nephropathy (MN) Antigens
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Overview of the Characteristics of a Phospholipase A2 Receptor (PLA2R)-Negative Membranous Nephropathy Cohort
10:00 AM - 12:00 PM
Overview of the Characteristics of a Phospholipase A2 Receptor (PLA2R)-Negative Membranous Nephropathy Cohort
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Sparsentan (SPAR) in Pediatric Patients with Rare Proteinuric Kidney Disease: Preliminary Findings from the EPPIK Study
10:00 AM - 12:00 PM
Sparsentan (SPAR) in Pediatric Patients with Rare Proteinuric Kidney Disease: Preliminary Findings from the EPPIK Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- "RESULT" Umbrella Trial in Primary Focal Segmental Glomerulosclerosis/Minimal Change Disease
10:00 AM - 12:00 PM
"RESULT" Umbrella Trial in Primary Focal Segmental Glomerulosclerosis/Minimal Change Disease
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Patient-Reported Outcomes in Adults with FSGS: Sparsentan vs. Irbesartan
10:00 AM - 12:00 PM
Patient-Reported Outcomes in Adults with FSGS: Sparsentan vs. Irbesartan
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Primary FSGS Patient Response to Immunosuppression (IS) and Risk of ESKD
10:00 AM - 12:00 PM
Primary FSGS Patient Response to Immunosuppression (IS) and Risk of ESKD
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Long-Term Outcomes of Patients with FSGS: A Multicenter Real-World Evidence (RWE) Study
10:00 AM - 12:00 PM
Long-Term Outcomes of Patients with FSGS: A Multicenter Real-World Evidence (RWE) Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Clinicopathologic Prognostic Factors to Estimate ESKD in Patients with FSGS
10:00 AM - 12:00 PM
Clinicopathologic Prognostic Factors to Estimate ESKD in Patients with FSGS
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Longitudinal Analysis of 100 Biopsy-Confirmed Focal Segmental Glomerulosclerosis: Incidence and Treatment Outcomes of a 10-Year, Single-Center Experience in Saudi Arabia
10:00 AM - 12:00 PM
Longitudinal Analysis of 100 Biopsy-Confirmed Focal Segmental Glomerulosclerosis: Incidence and Treatment Outcomes of a 10-Year, Single-Center Experience in Saudi Arabia
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Machine Learning-Derived Predictors of Clinical Outcomes in CureGN Participants with FSGS
10:00 AM - 12:00 PM
Machine Learning-Derived Predictors of Clinical Outcomes in CureGN Participants with FSGS
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Role of Neighborhood Disadvantage in Patient Outcomes in Childhood Nephrotic Syndrome in the CureGN Cohort
10:00 AM - 12:00 PM
Role of Neighborhood Disadvantage in Patient Outcomes in Childhood Nephrotic Syndrome in the CureGN Cohort
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Clinical Significance of Immune Deposits and Complement System Activation in Patients with FSGS: Findings from the CureGN Study
10:00 AM - 12:00 PM
Clinical Significance of Immune Deposits and Complement System Activation in Patients with FSGS: Findings from the CureGN Study
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Interplay between Immune Deposits, Complement Activation, and APOL1 Renal Risk Variants in Patients with FSGS
10:00 AM - 12:00 PM
Interplay between Immune Deposits, Complement Activation, and APOL1 Renal Risk Variants in Patients with FSGS
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Identification of Urinary Biomarkers for Outcome-Associated Digital Pathology Descriptors in Patients with Nephrotic Syndrome
10:00 AM - 12:00 PM
Identification of Urinary Biomarkers for Outcome-Associated Digital Pathology Descriptors in Patients with Nephrotic Syndrome
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Phase 1 Study in Healthy Adults of the Safety, Tolerability, and Pharmacokinetics of MZE829, an APOL1 Inhibitor, for the Treatment of APOL1-Mediated Kidney Disease (AMKD)
10:00 AM - 12:00 PM
A Phase 1 Study in Healthy Adults of the Safety, Tolerability, and Pharmacokinetics of MZE829, an APOL1 Inhibitor, for the Treatment of APOL1-Mediated Kidney Disease (AMKD)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Complement Activation Products in Kidneys of Patients with Primary Focal Segmental Glomerulosclerosis
10:00 AM - 12:00 PM
Complement Activation Products in Kidneys of Patients with Primary Focal Segmental Glomerulosclerosis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Efficacy and Safety of Rituximab in Patients with Focal Segmental Glomerulosclerosis (FSGS): A Single-Center Retrospective Cohort
10:00 AM - 12:00 PM
Efficacy and Safety of Rituximab in Patients with Focal Segmental Glomerulosclerosis (FSGS): A Single-Center Retrospective Cohort
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- A Pilot Study on the Efficacy and Safety of Rituximab in the Maintenance of Remission in Adults with Minimal Change Disease
10:00 AM - 12:00 PM
A Pilot Study on the Efficacy and Safety of Rituximab in the Maintenance of Remission in Adults with Minimal Change Disease
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Plasma Exchange and Rituximab for Prevention of Recurrent FSGS after Previous Graft Loss
10:00 AM - 12:00 PM
Plasma Exchange and Rituximab for Prevention of Recurrent FSGS after Previous Graft Loss
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Obinutuzumab in Children with Kidney Diseases: A Single-Center Experience
10:00 AM - 12:00 PM
Obinutuzumab in Children with Kidney Diseases: A Single-Center Experience
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Successful Treatment of Primary FSGS with LDL Apheresis
10:00 AM - 12:00 PM
Successful Treatment of Primary FSGS with LDL Apheresis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Characteristics of Dyslipidemia in Primary Nephrotic Syndromes
10:00 AM - 12:00 PM
Characteristics of Dyslipidemia in Primary Nephrotic Syndromes
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Lipidomics Analysis Reveals Biomarkers for Proteinuria Remission and Disease Progression in FSGS/Minimal Change Disease (MCD) from the NEPTUNE Cohort
10:00 AM - 12:00 PM
Lipidomics Analysis Reveals Biomarkers for Proteinuria Remission and Disease Progression in FSGS/Minimal Change Disease (MCD) from the NEPTUNE Cohort
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Association of Proteinuria Remission and Its Timing with Kidney Outcomes in Patients with Focal Segmental Glomerulosclerosis
10:00 AM - 12:00 PM
Association of Proteinuria Remission and Its Timing with Kidney Outcomes in Patients with Focal Segmental Glomerulosclerosis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Frequency of Adverse Events and Relapses after SARS-CoV-2 Vaccination in Patients with Podocytopathies
10:00 AM - 12:00 PM
Frequency of Adverse Events and Relapses after SARS-CoV-2 Vaccination in Patients with Podocytopathies
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Prediction of Response to Intensified Immunosuppression in Childhood Steroid-Resistant Nephrotic Syndrome by Multimodal Machine Learning
10:00 AM - 12:00 PM
Prediction of Response to Intensified Immunosuppression in Childhood Steroid-Resistant Nephrotic Syndrome by Multimodal Machine Learning
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Anti-slit Antibodies on Kidney Biopsy Identify Patients with Steroid-Resistant Nephrotic Syndrome Responsive to Second-Line Immunosuppressant and Hence Have a Good Prognosis
10:00 AM - 12:00 PM
Anti-slit Antibodies on Kidney Biopsy Identify Patients with Steroid-Resistant Nephrotic Syndrome Responsive to Second-Line Immunosuppressant and Hence Have a Good Prognosis
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Soluble Angiopoietins in Idiopathic Nephrotic Syndrome
10:00 AM - 12:00 PM
Soluble Angiopoietins in Idiopathic Nephrotic Syndrome
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Peripheral Blood Cell DNA Methylation Can Predict Steroid Response in Nephrotic Syndrome
10:00 AM - 12:00 PM
Peripheral Blood Cell DNA Methylation Can Predict Steroid Response in Nephrotic Syndrome
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Qualitative Findings for Preparing a Clinical Outcomes Assessment Set (COA) for Nephrotic Syndrome (Prepare-NS)
10:00 AM - 12:00 PM
Qualitative Findings for Preparing a Clinical Outcomes Assessment Set (COA) for Nephrotic Syndrome (Prepare-NS)
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Clinical Characteristics of Young and Elderly Patients with Minimal Change Nephrotic Syndrome
10:00 AM - 12:00 PM
Clinical Characteristics of Young and Elderly Patients with Minimal Change Nephrotic Syndrome
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
- Distinctions between C1q Nephropathy and Other Glomerular Diseases with Overlapping Clinical and Pathologic Features
10:00 AM - 12:00 PM
Distinctions between C1q Nephropathy and Other Glomerular Diseases with Overlapping Clinical and Pathologic Features
October 24, 2024 | 10:00 AM - 12:00 PM
Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.
